Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Evans R. Fernández Pérez
National Jewish Health
1400 Jackson Street
Denver, CO 80206
United States
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
171
TOTAL CITATIONS
3
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Pamrevlumab (FG-3019), an Anti-Connective Tissue Growth Factor Therapy for Idiopathic Pulmonary Fibrosis: A Randomized, Double-Blind, Placebo-Controlled Trial
Number of pages: 30
Posted: 03 May 2019
Luca Richeldi
, Evans R. Fernández Pérez,
Ulrich Costabel
,
Carlo Albera
,
David J. Lederer
,
Kevin R. Flaherty
,
Neil Ettinger
,
Rafael Perez
,
Mary Beth Scholand
,
Jonathan Goldin
,
Kin-Hung Peony Yu
,
Thomas Neff
,
Seth Porter
,
Ming Zhong
,
Eduard Gorina
,
Elias Kouchakji
and
Ganesh Raghu
Catholic University of Milan - Pneumology Complex Operating Unit, National Jewish Health, University of Duisburg-Essen - University Hospital Essen, University of Turin, Columbia University - Mailman School of Public Health, University of Michigan at Ann Arbor - Department of Internal Medicine, St. Luke's Hospital, University of Louisville, University of Utah, MedQIA, FibroGen, Inc., FibroGen, Inc., FibroGen, Inc. - Department of Clinical Development, FibroGen, Inc. - Department of Clinical Development, FibroGen, Inc., FibroGen, Inc. - Department of Clinical Development and University of Washington - Interstitial Lung Disease Clinic
Downloads
171
(440,151)
Citation
3
View PDF
Download
Abstract:
Feedback